132 related articles for article (PubMed ID: 12168111)
21. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India.
Katiyar S; Hedau S; Jain N; Kar P; Khuroo MS; Mohanta J; Kumar S; Gopalkrishna V; Kumar N; Das BC
Cancer Lett; 2005 Jan; 218(1):69-79. PubMed ID: 15639342
[TBL] [Abstract][Full Text] [Related]
22. [A study of p53 gene mutations in squamous cell carcinoma in eyes].
Niu Y; Yan Y; Ji J; Luo B
Zhonghua Yan Ke Za Zhi; 1999 May; 35(3):219-22. PubMed ID: 11835811
[TBL] [Abstract][Full Text] [Related]
23. TP53 and oesophageal cancer.
Ferec C; Giroux MA; Audrezet MP; Robaszkiewicz M
Pathol Biol (Paris); 1997 Dec; 45(10):871-5. PubMed ID: 9769951
[TBL] [Abstract][Full Text] [Related]
24. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681
[TBL] [Abstract][Full Text] [Related]
25. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T
J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067
[TBL] [Abstract][Full Text] [Related]
26. The impact of p53 protein core domain structural alteration on ovarian cancer survival.
Rose SL; Robertson AD; Goodheart MJ; Smith BJ; DeYoung BR; Buller RE
Clin Cancer Res; 2003 Sep; 9(11):4139-44. PubMed ID: 14519637
[TBL] [Abstract][Full Text] [Related]
27. [The relationship between p53 mutation and esophageal cancer biological behavior].
He Y; Li M; Shang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):1-4. PubMed ID: 9456364
[TBL] [Abstract][Full Text] [Related]
28. [Significance of p53 gene mutation and P53 protein expression abnormality on the prognosis of esophageal cancer: a meta-analysis study].
Wang XL; Zhang CM; Shi LY; Yu HP; Xu SQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):769-74. PubMed ID: 15555357
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.
Gibson MK; Abraham SC; Wu TT; Burtness B; Heitmiller RF; Heath E; Forastiere A
Clin Cancer Res; 2003 Dec; 9(17):6461-8. PubMed ID: 14695149
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
[TBL] [Abstract][Full Text] [Related]
31. Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast).
Paget V; Lechevrel M; Sichel F
Mutat Res; 2008 Mar; 652(1):12-9. PubMed ID: 18242117
[TBL] [Abstract][Full Text] [Related]
32. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.
Coggi G; Bosari S; Roncalli M; Graziani D; Bossi P; Viale G; Buffa R; Ferrero S; Piazza M; Blandamura S; Segalin A; Bonavina L; Peracchia A
Cancer; 1997 Feb; 79(3):425-32. PubMed ID: 9028350
[TBL] [Abstract][Full Text] [Related]
33. Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas.
Forslund A; Kressner U; Lindmark G; Inganäs M; Lundholm K
Int J Oncol; 2001 Sep; 19(3):501-6. PubMed ID: 11494027
[TBL] [Abstract][Full Text] [Related]
34. [Establishment of mouse p53 yeast functional assay and evaluation of its detectability of p53 gene mutation].
Tsunematsu I
Hokkaido Igaku Zasshi; 1999 Jul; 74(4):301-14. PubMed ID: 10480037
[TBL] [Abstract][Full Text] [Related]
35. High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast.
Pavlova S; Mayer J; Koukalova H; Smardova J
Int J Oncol; 2003 Jul; 23(1):121-31. PubMed ID: 12792784
[TBL] [Abstract][Full Text] [Related]
36. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
Hsu PK; Li AF; Wang YC; Hsieh CC; Huang MH; Hsu WH; Hsu HS
J Thorac Cardiovasc Surg; 2008 May; 135(5):1029-35. PubMed ID: 18455580
[TBL] [Abstract][Full Text] [Related]
37. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
38. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression.
Hanazono K; Natsugoe S; Stein HJ; Aikou T; Hoefler H; Siewert JR
Oncol Rep; 2006 Apr; 15(4):821-4. PubMed ID: 16525665
[TBL] [Abstract][Full Text] [Related]
39. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
[TBL] [Abstract][Full Text] [Related]
40. p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.
Sengpiel C; König IR; Rades D; Noack F; Duchrow M; Schild SE; Ludwig D; Homann N
Cancer Invest; 2009 Jan; 27(1):96-104. PubMed ID: 19160092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]